Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04155580
Status:
TERMINATED
Last Update Posted:
2023-02-21
First Post:
2019-11-05
Brief Title:
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With RelapsedRefractory Acute Myeloid Leukemia AML
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc
Organization Data
Organization:
Astex Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ASTX660-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Astex Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None